Empowering patients through shared knowledge and community-driven health insights.
The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
© 2026 MedInfo World. All rights reserved.
Deutivacaftor – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Home Active Ingredients Deutivacaftor Deutivacaftor Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
1 Drug 2 Variants
Category
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
Important Notice This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Deutivacaftor.
Chloride Channel Activation Potentiators [MoA] Cytochrome P450 2C9 Inhibitors [MoA] P-Glycoprotein Inhibitors [MoA] Breast Cancer Resistance Protein Inhibitors [MoA]
RxCUI
2701438, 2701444, 2701448, 2701450
UNII
8RW88Y506K, COM1POP492, SHA6U5FJZL
Drugs with Deutivacaftor Medications containing this ingredient
1